| Literature DB >> 32974103 |
Marc Terradas-Monllor1,2,3,4, Mirari Ochandorena-Acha1,2, Julio Salinas-Chesa3, Sergi Ramírez3, Hector Beltran-Alacreu5,6.
Abstract
BACKGROUND: Knee arthroplasty (KA) is a typically successful surgical procedure commonly performed to alleviate painin participants with end-stage knee osteoarthritis. Despite its beneficial effects, a significant proportion of individuals with KA continue experiencing persistent pain and functional limitations. The purpose of this study was to assess the postoperative outcomes after KA in relation to postoperative pain catastrophizing.Entities:
Keywords: Knee arhtroplasty; Pain catastrophizing; Rehabilitation
Year: 2020 PMID: 32974103 PMCID: PMC7486825 DOI: 10.7717/peerj.9903
Source DB: PubMed Journal: PeerJ ISSN: 2167-8359 Impact factor: 2.984
Figure 1Flowchart of KA patients (screening, inclusion and assessment at all data points).
Sociodemographic and health characteristics of participants.
| Age (SD) | 70.17 (7.6) | 70.30 (7.05) | 0.947 |
| Sex | |||
| Male, | 10 (33.3%) | 9 (30%) | 0.781 |
| Female, | 20 (66.7%) | 21 (70%) | |
| Body mass index (BMI) | 29.69 (4.39) | 30.60 (4.35) | |
| Normal, | 4 (13.3%) | 3 (10%) | |
| Overweight, | 13 (43.3%) | 11 (36.7%) | 0.598 |
| Type I Obesity, | 8 (26.7%) | 11 (36.7%) | |
| Type II Obesity, | 4 (13.3%) | 4 (13.3%) | |
| Type III Obesity, | 1 (3.3%) | 1 (3.3%) | |
| Charlson Comorbidity Index (CCI) | |||
| 1, | 1 (3.3%) | 0 | |
| 2, | 9 (30%) | 9 (30%) | |
| 3, | 10 (33.3%) | 15 (50%) | 0.582 |
| 4, | 8 (26.7%) | 5 (16.7%) | |
| 5, | 1 (3.3%) | 1 (3.3%) | |
| 6, | 1 (3.3%) | 0 | |
| Smoking | |||
| Never smoked, | 20 (66.7%) | 21 (70%) | |
| Quit smoking, | 9 (30%) | 7 (23.3%) | 1.000 |
| Smoker, | 1 (3.3%) | 2 (6.7%) | |
| Alcohol | |||
| Never, | 10 (33.3%) | 13 (43.3%) | 0.238 |
| Minimal consumption, | 18 (60%) | 17 (56.7%) | |
| Usual consumption, | 2 (6.7%) | 0 | |
| Type of surgery | |||
| TKA, | 10 (33.3%) | 11 (36.7%) | 0.787 |
| UKA, | 20 (66.7%) | 19 (63.3%) | |
| Education level | |||
| Read and write, | 12 (40%) | 13 (43.3%) | |
| Elementary, intermediate, | 12 (40%) | 10 (33.3%) | 0.761 |
| Secondary, vocational, | 6 (20%) | 5 (16.7%) | |
| University, | 0 | 2 (6.7%) |
Notes.
Independent samples t-test.
Pearson’s chi-squared test.
Linear chi-squared test.
Outcome measures between groups.
| WOMAC (0–96 range) | ||||||
| 1 week | 29 (21 and 45) | 50 (41.75 and 65.29) | 155 | −4.363 | .000 | .563 |
| 1 month | 20.5 (13.75 and 26.5) | 34 (23.75 and 53.25) | 200 | −3.699 | .000 | .578 |
| 3 months | 15 (7.75 and 26) | 30 (11.50 and 46.25) | 267.5 | −2.700 | .007 | .349 |
| 6 months | 9 (5 and 19) | 28.5 (8.50 and 39) | 210 | −3.416 | .001 | .445 |
| WOMAC pain (0–20 range) | ||||||
| 1 week | 5.5 (3 and 7) | 9 (7.38 and 11.44) | 125.5 | −4.820 | .000 | .622 |
| 1 month | 4 (2 and 6) | 7 (4.75 and 10.25) | 207.5 | −3.602 | .000 | .465 |
| 3 months | 3 (1 and 5) | 5.5 (2 and 10.25) | 296 | −2.288 | .022 | .295 |
| 6 months | 2 (1 and 3) | 6 (2 and 8.25) | 228.5 | −3.157 | .002 | .411 |
| WOMAC stiffness (0–8 range) | ||||||
| 1 week | 2.5 (2 and 4) | 4 (3 and 5.25) | 202.5 | −3.737 | .000 | .482 |
| 1 month | 2 (1 and 3) | 3.5 (3 and 4.25 | 236.5 | −3.222 | .001 | .416 |
| 3 months | 1.5 (1 and 3) | 3 (1 and 4.25) | 317.5 | −1.999 | .046 | .258 |
| 6 months | 1 (0 and 1.5) | 2 (.75 and 4) | 269.5 | −2.596 | .009 | .338 |
| WOMAC disability (0–68 range) | ||||||
| 1 week | 21.5 (16 and 34.5) | 37.20 (30.75 and 50) | 178 | −4.023 | .000 | .519 |
| 1 month | 15 (9.75 and 19) | 23.50 (16.25 and 36) | 213.5 | −3.501 | .000 | .452 |
| 3 months | 11.5 (4.75 and 18.25) | 22 (7.75 and 30) | 262 | −2.782 | .005 | .359 |
| 6 months | 5 (3.50 and 14) | 19 (6.50 and 27.5) | 198 | −3.601 | .000 | .469 |
| EQ–5D–5L (0–1 range) | ||||||
| 1 week | .608 (.527 and .527) | .281 (.076 and .480) | 131.5 | −4.710 | .000 | .608 |
| 1 month | .728 (.636 and .849) | .648 (.354 and .748) | 276.5 | −2.668 | .010 | .332 |
| 3 months | .849 (.742 and .910) | .721 (.590 and .843) | 289.5 | −2.379 | .017 | .307 |
| 6 months | .910 (.412 and .759) | .709 (.562 and .897) | 222 | −3.258 | .001 | .424 |
| 4MWT (meters/second) | ||||||
| 1 week | .599 (.412 and .759) | .413 (.309 and .727) | 308 | −2.100 | .036 | .271 |
| 1 month | .812 (.676 and 1.063) | .780 (.553 and 1.002) | 390.5 | −.880 | .379 | .114 |
| 3 months | 1.127 (.889 and 1.194) | .920 (.791 and 1.022) | 286.5 | −2.417 | .016 | .312 |
| 6 months | 1.226 (.949 and 1.434) | 1.041 (.791 and 1.167) | 321 | −1.728 | .084 | .225 |
| 30s CST (repetitions) | ||||||
| 1 week | 6 (2.25 and 9) | 0.5 (.00 and 5.25) | 255 | −2.965 | .003 | .284 |
| 1 month | 9.5 (6 and 12.25) | 7 (4.75 and 10) | 302 | −2.196 | .028 | .284 |
| 3 months | 12 (9 and 14) | 9 (6 and 11.25) | 258.5 | −2.844 | .004 | .367 |
| 6 months | 12 (9 and 15) | 12 (9 and 15) | 248.5 | −2.838 | .005 | .369 |
| Active knee flexion (degrees) | ||||||
| 1 week | 85 (70 and 95) | 80 (65 and 90) | 376 | −1.100 | .271 | .142 |
| 1 month | 102.5 (90 and 110) | 100 (90 and 110) | 439 | −.164 | .870 | .021 |
| 3 months | 110 (100 and 116.25) | 110 (100 and 116.25) | 446.5 | −.052 | .958 | .007 |
| 6 months | 115 (110 and 122.5) | 110 (105 and 125) | 403.5 | −.482 | .630 | .063 |
| Active knee extension (degrees) | ||||||
| 1 week | −10 (−11.25 and −8.75) | −10 (−15 and −10) | 385.5 | −1.043 | .279 | .135 |
| 1 month | −10 (−10 and −5) | −10 (−10 and −5) | 406 | −0.701 | .483 | .090 |
| 3 months | −5 (−5 and 0) | −5 (−10 and −5) | 347 | −1.646 | .100 | .212 |
| 6 months | 0 (−5 and 0) | −5 (−5 and 0) | 310.5 | −2.063 | .039 | .269 |
| VAS Rest (0–10 range) | ||||||
| 1 week | 3 (1.375 and 4) | 5.75 (4 and 7) | 147.5 | −4.502 | .000 | .581 |
| 1 month | 2 (.75 and 3.25) | 4 (2 and 7) | 252.5 | −2.948 | .003 | .381 |
| 3 months | 0 (0 and 2) | 3.5 (0 and 6) | 267.5 | −2.824 | .005 | .365 |
| 6 months | 0 (0 and 1.5) | 2 (0 and 5) | 230.5 | −3.255 | .001 | .424 |
| VAS Walking (0–10 range) | ||||||
| 1 week | 3 (1 and 4.125) | 6 (4.75 and 8) | 151 | −4.438 | .000 | .573 |
| 1 month | 2 (1 and 4) | 5 (2.75 and 7) | 231.5 | −3.249 | .001 | .419 |
| 3 months | 3 (0 and 5) | 4.5 (2 and 6.25) | 319 | −1.954 | .051 | .252 |
| 6 months | 2 (0 and 3.25) | 3 (1.75 and 6) | 258.5 | −2.703 | .007 | .352 |
| VAS Flexion (0–10 range) | ||||||
| 1 week | 6 (3 and 7) | 8 (7 and 9) | 175.5 | −4.101 | .000 | .529 |
| 1 month | 3 (2 and 6) | 7 (5 and 9) | 174.5 | −4.096 | .000 | .529 |
| 3 months | 3.25 (.75 and 5) | 5 (3 and 8) | 244 | −3.066 | .002 | .396 |
| 6 months | 2 (0 and 3.5) | 3.75 (2 and 6) | 251.5 | −2.802 | .005 | .365 |
Notes.
Pain Catastrophizing Scale
Western Ontario and McMaster Osteoarthritis Index
Euro Quality of Life 5 Dimensions—5 Levels
4 Meters Walking Test
30-second Chair Stand Test
Visual Analog Scale
Mann Whitney’s U
Effect size
Small effect size 0.1–0.29.
Medium effect size 0.3–0.49.
Large effect size > 0.5.
Outcome measures within groups.
| WOMAC (0–96 range) | Low PCS | .000 | .000 |
| High PCS | .000 | .000 | |
| WOMAC Pain (0–20 range) | Low PCS | .000 | .003 |
| High PCS | .000 | .001 | |
| WOMAC Stiffness (0–8 range) | Low PCS | .000 | .073 |
| High PCS | .000 | .023 | |
| WOMAC Disability (0–68 range) | Low PCS | .000 | .000 |
| High PCS | .000 | .000 | |
| EQ-5D-5L (0–1 range) | Low PCS | .000 | .000 |
| High PCS | .000 | .000 | |
| 4MWT (meters/second) | Low PCS | .000 | .000 |
| High PCS | .000 | .000 | |
| 30s CST (repetitions) | Low PCS | .000 | .000 |
| High PCS | .000 | .000 | |
| Active Knee Flexion (degrees) | Low PCS | .000 | .000 |
| High PCS | .000 | .000 | |
| Active Knee Extension (degrees) | Low PCS | .000 | .001 |
| High PCS | .000 | .001 | |
| VAS Rest (0–10 range) | Low PCS | .000 | .015 |
| High PCS | .000 | .007 | |
| VAS Walking (0–10 range) | Low PCS | .042 | .452 |
| High PCS | .000 | .010 | |
| VAS Flexion (0–10 range) | Low PCS | .000 | .007 |
| High PCS | .000 | .002 |
Notes.
Pain Catastrophizing Scale
Western Ontario and McMaster Osteoarthritis Index
Euro Quality of Life 5 Dimension—5 Levels
4 Meters Walking Test
30-second Chair Stand Test
Visual Analog Scale
1 week vs. 1 month.
1 week vs. 3 months.
1 week vs. 6 months.
1 month vs. 3 months.
1 month vs. 6 months.
3 months vs. 6 months.